Key terms

About GLPG

Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. Its clinical pipeline includes filgotinib, GLP3667, Toledo program, and idiopathic pulmonary fibrosis. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest GLPG news

May 04 9:45pm ET Kepler Capital Sticks to Their Hold Rating for Galapagos (GLPG) by TipRanks May 03 11:28am ET Galapagos NV Reports Strong Q1 2024 Financials by TipRanks May 02 4:44pm ET Galapagos reports Q1 EPS EUR1.37 vs EUR.35 last year by TipRanks May 01 6:27pm ET Galapagos NV Shareholders Approve Key Resolutions by TipRanks May 01 7:30am ET Galapagos NV Shareholders Approve Key Resolutions by TipRanks Apr 08 10:27am ET Galapagos NV Unveils CAR-T Therapy Advances by TipRanks Apr 04 4:19pm ET Galapagos announces clinical/ translational data on hematological cancer care by TipRanks Apr 01 9:50am ET Crocs initiated, Bill downgraded: Wall Street’s top analyst calls by TipRanks Apr 01 6:11am ET Galapagos downgraded to Underperform from Neutral at BofA by TipRanks Mar 29 6:27pm ET Galapagos NV Announces Shareholders’ Meetings and 2023 Report by TipRanks Mar 29 7:01am ET Galapagos NV Welcomes New Board Member by TipRanks Mar 28 9:52am ET Palantir downgraded, CyberArk initiated: Wall Street’s top analyst calls by TipRanks Mar 28 6:07am ET Galapagos downgraded to Underperform from Neutral at BofA by TipRanks Mar 08 12:01pm ET Galapagos price target lowered to EUR 35 from EUR 36 at Morgan Stanley by TipRanks Mar 06 8:24pm ET Galapagos assumed with an Equal Weight at Morgan Stanley by TipRanks Feb 27 6:47am ET Galapagos price target lowered to $41 from $44 at BofA by TipRanks Feb 26 8:45pm ET Galapagos (GLPG) Gets a Hold from RBC Capital by TipRanks Feb 26 3:22pm ET Galapagos price target lowered to EUR 33 from EUR 37 at Barclays by TipRanks Feb 23 2:25pm ET TD Cowen Sticks to Their Buy Rating for Galapagos (GLPG) by TipRanks Feb 22 4:04pm ET Galapagos reports FY23 revenue EUR 543.8M vs EUR 264M last year by TipRanks

No recent press releases are available for GLPG

GLPG Financials

1-year income & revenue

Key terms

GLPG Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

GLPG Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

People shop in a supermarket in the Manhattan borough of New York city on January 27, 2024. (Photo by Charly TRIBALLEAU / AFP) (Photo by CHARLY TRIBALLEAU/AFP via Getty Images)
Charly Triballeau/AFP/Getty Images
Americans have spent their savings. Economists worry about what comes next
Berkshire Hathaway Chairman Warren Buffett walks through the exhibit hall as shareholders gather to hear from the billionaire investor at Berkshire Hathaway Inc's annual shareholder meeting in Omaha, Nebraska, on May 4, 2019.
Scott Morgan/Reuters/File
Warren Buffett compares AI to nuclear weapons in stark warning
The US Securities and Exchange Commission (SEC) headquarters in Washington, DC, US, on Wednesday, Jan. 10, 2024. The SEC's X account was compromised and a fake post claiming that the agency had green lit plans for a spot-Bitcoin exchange-traded fund fueled a brief surge in the price of the world's biggest cryptocurrency. Photographer: Graeme Sloan/Bloomberg via Getty Images
Graeme Sloan/Bloomberg/Getty Images
Trump Media fires accounting firm after old one accused of being a ‘sham audit mill’
People walk by the New York Stock Exchange (NYSE) on March 06, 2024 in New York City.
Spencer Platt/Getty Images
Three things investors probably don’t know, but should